We are dedicated to developing better bioengineered tools to address unmet biomedical needs and biological questions. Through working at the interface of material sciences, biomedical engineering, biology and medicine, our interdisciplinary and collaborative team aims to develop next generation stem cell-based therapeutics and miniaturized diagnostics (Research). We are also fully committed to the professional development of the personnel in the laboratory and do everything we can to ensure successful career paths (Education). If you are interested in joining the team, collaborating, donating, or are interested in what our research expertise can do for you, please contact Dr. Weian Zhao (firstname.lastname@example.org).
Multiple positions available for highly motivated Postdocs, Graduate Students, Undergraduate students and Administrative Staffs who want to join an interdisciplinary and collaborative team to address unmet challenges in medicine. The applicants who have a background/interest in immunology, stem cell and cancer biology, in vitro selection and evolution, bioengineering and technology translation, and clinical oncology are particularly encouraged to apply.
November 13, 2014: Zhao lab Launches Velox Biosystems, startup aiming to transform rapid and sensitive diagnostics.
November 13, 2014: Congratulations to our Nature Communications paper. “Rapid detection of single bacteria in unprocessed blood using Integrated Comprehensive Droplet Digital Detection.” Nature Communications, 2014, 5, 5427. Selected as Featured paper, Featured at UCI news.
October 07, 2014: Congratulations to Dr. Weian Zhao who is selected for a prestigious National Institutes of Health Director’s New Innovator Award with $1.5 million over five years. He’s among 50 investigators selected for the 2014 award.
October 06, 2014: Congratulations to Dr. Dong-Ku Kang who is selected for Tony B. Academic Award from Society for Laboratory Automation and Screening (SLAS) and he is also invited as a Podium speaker at SLAS2015 international conference in Washington DC.